News Archive
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to welcome LaQuandra S. Nesbitt, MD, MPH, immediate-past director of DC Health, to serve as the new executive director of the Center for Population Health Sciences and Health Equity.
Janani Rangaswami, MD, director of the cardiorenal program at George Washington University in Washington, D.C., said the new study provides doctors the means to help patients understand the value of statins versus supplements.
Cold and flu season is upon us, and this year respiratory syncytial virus, or RSV, has joined the COVID-19 variants as complicating factors. Learn how to tell the difference among them and what you can do to protect yourself.
Julie E. Bauman, MD, MPH, associate dean of cancer and professor of medicine at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) was installed as the Dr. Cyrus Katzen Family Director of the GW Cancer Center.
Mamoun Younes, MD, professor of pathology at GW School of Medicine and Health Sciences, was among nearly 80 pathologists from leading universities across the country who signed on to an open letter to the U.S. Congress, in the Oct. 20 edition of Nature Medicine, calling for modernization of the…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) welcomed alumni from 10 MD program graduation classes to celebrate major anniversary milestones from 10 to 50 years during the annual Reunion Weekend.
“There have been several studies showing that an earlier diagnosis of breast cancer below the age of 50 can potentially increase the risk for melanoma — the most dangerous of all skin cancers — up to 40 to 50% compared to those without breast cancer,” said Dr. Adam Friedman, professor and chair…
The George Washington University School of Medicine & Health Sciences and Medi-Corps Program brought their Immersive Learning Center to West Potomac Tuesday morning.
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific vaccines. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and…
At a moment when the global COVID-19 pandemic is finally loosening its grip on the public consciousness as an object of existential dread, a new fear has swept in to supplant it: nuclear annihilation. Assistant Professor Amir Afkhami, MD, from the department of Psychiatry and Behavioral Sciences…